profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
martijn-den-brok-63bb5b6,Martijn,den Brok,Head of Biology at Tagworks Pharmaceuticals,,https://media.licdn.com/dms/image/D4E16AQE1cgN1dPgT5w/profile-displaybackgroundimage-shrink_350_1400/0/1687522807235?e=1697673600&v=beta&t=O-0TA2f4oGD_oI4vf_NglS6sxx7aWgzUrefxNxgZzuc,personal,ACoAAAE9Bs8B2bQPnrZVrs1IYHilZKLOxc4CuSA,20776655,,"I am an experienced scientist with a passion for tumor immunology, currently working at Tagworks Pharmaceuticals.  

In my jobs Immuno-Oncology always took the center stage. Clinical translation of (academic) results with partners in biotech and pharma is an important element of my work. With this I learned about the specific needs present in these different worlds (Academia, Industry, Regulatory bodies).  

Specific expertise: Cancer Immunotherapy (Immuno-Oncology), Immunology, Oncology, Intervention Radiology, Drug Discovery & Development, R&D, Biobanking, Chemistry.
Immunological assays, Cell-based assays, Vaccine adjuvants, Flowcytometry, Mouse models, Tumor models, Vaccines, Bioinformatics, Click-chemistry, Antibodies, Protein expression.
Project Management, Trial Management, Team leadership & Coaching, Collaborations academia-industry, Grant-writing, Innovation, Contract research.

I am always open to hear about job opportunities and new collaboration projects.


Banner courtesy: Freepik.com","{'country': 'Netherlands', 'short': 'Nijmegen, Gelderland', 'city': 'Nijmegen', 'state': 'Gelderland', 'default': 'Nijmegen, Gelderland, Netherlands'}",False,False,[],"{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'English', 'proficiency': None}, {'name': 'German', 'proficiency': None}]}",Biotechnology,"[{'date': {'start': {'month': None, 'day': None, 'year': 1996}, 'end': {'month': None, 'day': None, 'year': 2000}}, 'school': {'name': 'Radboud University', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQHgdni-2v0psQ/company-logo_400_400/0/1670846116863?e=1700697600&v=beta&t=vgJeC3CA6j7MZM594LPJ9niyV2uONRQXRNwcseFWVLI', 'url': 'https://www.linkedin.com/school/radboud-university-nijmegen/'}, 'degree_name': 'Drs.', 'field_of_study': 'Biomedical health sciences'}, {'date': {'start': {'month': None, 'day': None, 'year': 1990}, 'end': {'month': None, 'day': None, 'year': 1996}}, 'school': {'name': 'Gymnasium Bernrode', 'logo': None, 'url': None}, 'degree_name': None, 'field_of_study': None}, {'date': {'start': {'month': None, 'day': None, 'year': 1983}, 'end': {'month': None, 'day': None, 'year': 1990}}, 'school': {'name': ""Basisschool 't Maxend"", 'logo': None, 'url': None}, 'degree_name': None, 'field_of_study': None}]",[],[],"[{'name': 'Ken Blanchard on Servant Leadership', 'date': {'start': {'month': 10, 'day': None, 'year': 2018}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': 'LinkedIn', 'url': 'https://www.linkedin.com/learning/certificates/dc67410f591c7e8693fa94b3374f924ab0270d62a0aee73141443a0d986fbe5e?trk=backfilled_certificate', 'license_number': None, 'display_source': 'linkedin.com', 'company': {'id': None, 'name': 'LinkedIn', 'logo': 'https://media.licdn.com/dms/image/C560BAQHaVYd13rRz3A/company-logo_400_400/0/1638831589865?e=1700697600&v=beta&t=e1FsZytsym0fLF5Jt7PFnH40bqJRRzdgJ5LH7Y3pJJM', 'url': None}}, {'name': 'Certificate working according to GMP', 'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': None, 'url': None, 'license_number': None, 'display_source': None, 'company': None}, {'name': 'Nationally approved certificate on experimental animal usage (art. 9)', 'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': None, 'url': None, 'license_number': None, 'display_source': None, 'company': None}, {'name': 'Nationally approved certificate on working with radioactivity (level 5b)', 'date': {'start': {'month': None, 'day': None, 'year': None}, 'end': {'month': None, 'day': None, 'year': None}}, 'authority': None, 'url': None, 'license_number': None, 'display_source': None, 'company': None}]",[],[],"[{'name': 'Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation', 'publisher': 'Nature Communications', 'url': 'http://www.nature.com/articles/ncomms13324', 'date': {'month': None, 'day': None, 'year': 2016}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Martijn', 'last_name': 'den Brok', 'name': None, 'headline': 'Head of Biology at Tagworks Pharmaceuticals'}, {'type': 'standardizedContributor', 'first_name': 'Christian', 'last_name': 'Büll', 'name': None, 'headline': 'Assistant Professor, Group Leader, Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University'}, {'type': 'standardizedContributor', 'first_name': 'Annemarie', 'last_name': 'de Graaf', 'name': None, 'headline': 'Research Technician at LUMC'}, {'type': 'standardizedContributor', 'first_name': 'Marthe', 'last_name': 'Minderman', 'name': None, 'headline': 'Biomedical Scientist | DevOps (.NET) Engineer'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'amigorena, sebastian', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'thakur, mayank', 'headline': None}, {'type': 'standardizedContributor', 'first_name': 'Eric', 'last_name': 'Rijke', 'name': None, 'headline': 'Scientific manager at Intervet International'}, {'type': 'standardizedContributor', 'first_name': 'Carla', 'last_name': 'S.', 'name': None, 'headline': 'R&D consultant Animal Health'}, {'type': 'standardizedContributor', 'first_name': 'Gosse', 'last_name': 'Adema', 'name': None, 'headline': 'Professor in Molecular Immunology at the new Radiotherapy & OncoImmunology laboratoria, Department of Radiation Oncology'}]}, {'name': 'Recognition of Coxiella burnetii by Toll-like receptors and NOD-like receptors', 'publisher': 'Journal of Infectious Diseases', 'url': 'http://www.ncbi.nlm.nih.gov/pubmed/25246533', 'date': {'month': None, 'day': None, 'year': 2014}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Martijn', 'last_name': 'den Brok', 'name': None, 'headline': 'Head of Biology at Tagworks Pharmaceuticals'}, {'type': 'standardizedContributor', 'first_name': 'Anne', 'last_name': 'Ammerdorffer', 'name': None, 'headline': 'Research Manager at Concept Foundation'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Teske Schoffelen', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Mark Gresnigt', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Marije Oosting', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Thirumala-Devi Kanneganti', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Marcel van Deuren', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Hendrik Jan Roest', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Annemarie Rebel', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'tom sprong', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Shahla Abdollahi-Roodsaz', 'headline': None}]}, {'name': 'Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis.', 'publisher': 'Mucosal Immunology', 'url': 'http://www.nature.com/mi/journal/vaop/ncurrent/full/mi201416a.html', 'date': {'month': None, 'day': None, 'year': 2014}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Martijn', 'last_name': 'den Brok', 'name': None, 'headline': 'Head of Biology at Tagworks Pharmaceuticals'}, {'type': 'standardizedContributor', 'first_name': 'Mary', 'last_name': 'Morgan', 'name': None, 'headline': 'Medical Writer at Fishawack Communications'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Pim Koelink', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Bin Zheng', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'HJG van de Kant', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'HW Verspaget', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Gert Folkerts', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'G. Adema', 'headline': None}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Aletta D. Kraneveld', 'headline': None}]}, {'name': 'DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells', 'publisher': 'BMC Immunol', 'url': 'http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199277/', 'date': {'month': None, 'day': None, 'year': 2011}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Martijn', 'last_name': 'den Brok', 'name': None, 'headline': 'Head of Biology at Tagworks Pharmaceuticals'}, {'type': 'standardizedContributor', 'first_name': 'Marleen', 'last_name': 'Ansems', 'name': None, 'headline': 'Assistant Professor at the Department of Radiation Oncology, RIMLS, RadboudUMC, The Netherlands'}, {'type': 'standardizedContributor', 'first_name': 'Anna', 'last_name': 'Sanecka-Duin, PhD', 'name': None, 'headline': 'Lead Scientist Immuno-Oncology at Ardigen'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Amy Prosser', 'headline': None}, {'type': 'standardizedContributor', 'first_name': 'Katharina', 'last_name': 'Danielski', 'name': None, 'headline': 'Senior Field Application Scientist at ScaleBio'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Kathrin Warner', 'headline': None}, {'type': 'standardizedContributor', 'first_name': 'Bastiaan', 'last_name': 'Jansen', 'name': None, 'headline': 'Scientist Molecular & Cellular Biology working in target discovery, biomarker identification and drug discovery'}, {'type': 'standardizedContributor', 'first_name': 'Dagmar', 'last_name': 'Eleveld-Trancikova', 'name': None, 'headline': 'Scientific policy advisor | Team player | Enthusiastic | Personal and career development | Recognition and rewards in science | Organisationally sensitive | Wants to make the world a better place'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Gosse Adema', 'headline': None}]}]",[],[],"[{'company': {'id': 2931522, 'name': 'Tagworks Pharmaceuticals', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQHR5vGDb_9uwg/company-logo_400_400/0/1687329579460?e=1700697600&v=beta&t=wrE81Vyq3EZVtZI2obcT5Zmr_oHEg6N6eGcr-TUbwsY', 'url': 'https://www.linkedin.com/company/tagworks-pharmaceuticals/', 'employees': {'start': 11, 'end': 50}}, 'date': {'start': {'month': 2, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Nijmegen, Gelderland, Netherlands', 'date': {'start': {'month': 2, 'day': None, 'year': 2023}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Tagworks Pharmaceuticals', 'description': None, 'title': 'Head of Biology', 'employment_type': None}, {'location': 'Nijmegen Area, Netherlands', 'date': {'start': {'month': 2, 'day': None, 'year': 2019}, 'end': {'month': 2, 'day': None, 'year': 2023}}, 'company': 'Tagworks Pharmaceuticals', 'description': 'Tagworks develops in vivo chemistry to improve the efficacy of cancer therapies. Using a revolutionary cleavable linker system we can react drugs in vivo, on demand. My role is to design and develop new immunological and biological assets.', 'title': 'Senior Scientist', 'employment_type': None}]}, {'company': {'id': 12199, 'name': 'Radboudumc', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQH1GYL46xdJmg/company-logo_400_400/0/1580825512622?e=1700697600&v=beta&t=O1e6HjHi14S4JPLU-BI-EFsBLoUlSpzhgJCy6AoDcyI', 'url': 'https://www.linkedin.com/company/radboudumc/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2019}, 'end': {'month': 11, 'day': None, 'year': 2021}}, 'profile_positions': [{'location': 'Nijmegen Area, Netherlands', 'date': {'start': {'month': 4, 'day': None, 'year': 2019}, 'end': {'month': 11, 'day': None, 'year': 2021}}, 'company': 'Radboudumc', 'description': 'Using oncological biobanking and molecular or biological screening we tried to link individual tumors with their optimal treatment. We focussed on checkpoint-blockade inhibitors in particular. My roles involved project design, development and funding.', 'title': 'Project Manager / Sr. Postdoc', 'employment_type': None}]}, {'company': {'id': None, 'name': 'ERC immunotherapy', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 3, 'day': None, 'year': 2021}}, 'profile_positions': [{'location': 'Schaijk', 'date': {'start': {'month': 8, 'day': None, 'year': 2019}, 'end': {'month': 3, 'day': None, 'year': 2021}}, 'company': 'ERC immunotherapy', 'description': 'ERC immunotherapeutics is developing an autologous ATMP product for the treatment of glioblastoma. My role as Research Manager was to guide the US-based Phase II and Right to Try activities.', 'title': 'Research Manager', 'employment_type': None}]}, {'company': {'id': 1727619, 'name': 'Triskelion B.V. | a TNO initiative', 'logo': 'https://media.licdn.com/dms/image/C560BAQGZaNlunxpsJg/company-logo_400_400/0/1580376051417?e=1700697600&v=beta&t=6kz7SgiqYTG8jN-ixBNOteSpyc_VD6Ycf6Gdncepo4o', 'url': 'https://www.linkedin.com/company/triskelion-/', 'employees': {'start': 51, 'end': 200}}, 'date': {'start': {'month': 12, 'day': None, 'year': 2017}, 'end': {'month': 11, 'day': None, 'year': 2018}}, 'profile_positions': [{'location': 'Zeist', 'date': {'start': {'month': 12, 'day': None, 'year': 2017}, 'end': {'month': 11, 'day': None, 'year': 2018}}, 'company': 'TRISKELION', 'description': 'The C.R.O. Triskelion B.V. performed scientific studies for partners in the (pharmaceutical) industry. In my role as Study Director I managed the design and planning of in vitro and in vivo studies, and supervised correct completion. My area of expertise was Immuno-Oncology. Additional roles were Scientitic contributor and Project Manager. A large part of the company was dissolved in 2018-19.', 'title': 'Study Director', 'employment_type': None}]}, {'company': {'id': 12199, 'name': 'Radboudumc', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQH1GYL46xdJmg/company-logo_400_400/0/1580825512622?e=1700697600&v=beta&t=O1e6HjHi14S4JPLU-BI-EFsBLoUlSpzhgJCy6AoDcyI', 'url': 'https://www.linkedin.com/company/radboudumc/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 5, 'day': None, 'year': 2017}, 'end': {'month': 11, 'day': None, 'year': 2017}}, 'profile_positions': [{'location': 'Nijmegen Area, Netherlands', 'date': {'start': {'month': 5, 'day': None, 'year': 2017}, 'end': {'month': 11, 'day': None, 'year': 2017}}, 'company': 'Radboudumc', 'description': 'Department of Radiation Oncology, Radiotherapy & OncoImmunology Laboratory, RIMLS, \nProjects include: \n-Lipid bodies and their function in cross-presentation by dendritic cells (DCs). A KWF-funded study\n-Tumor destruction and DC activation in situ: combining danger signals from ‘foreign’ and ‘self’. A collaboration with MSD Animal Health (Intervet)\n-Exploiting in situ tumor destruction techniques in anti-tumor immunity. A collaboration with Tel Aviv University\n-MRI-guided high-intensity focused US ablation and immune activation.\n-The impact of anesthetics and analgesics on anti-tumor immunity.\n-Many other projects', 'title': 'Senior Postdoctoral Researcher', 'employment_type': None}]}, {'company': {'id': None, 'name': 'Department of Tumor Immunology, RIMLS, RadboudUMC', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 8, 'day': None, 'year': 2007}, 'end': {'month': 5, 'day': None, 'year': 2017}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 8, 'day': None, 'year': 2007}, 'end': {'month': 5, 'day': None, 'year': 2017}}, 'company': 'Department of Tumor Immunology, RIMLS, RadboudUMC', 'description': 'Projects include: \n-Lipid bodies and their function in cross-presentation by DCs. A KWF-funded study\n-Tumor destruction and DC activation in situ: combining danger signals from ‘foreign’ and ‘self’. A collaboration with Intervet International BV (MSD)\n-Exploiting in situ tumor destruction techniques in anti-tumor immunity. A collaboration with Tel Aviv University\n-MRI-guided high-intensity focused US ablation and immune activation. A collaboration with RUMC dept. Radiology\n-The impact of anesthetics and analgesics on anti-tumor immunity. A collaboration with RUMC dept. of Anesthesiology.\n-Various other projects', 'title': 'Postdoctoral Researcher', 'employment_type': None}]}, {'company': {'id': 35462, 'name': 'Synthon', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQGq3mDMChDjvw/company-logo_400_400/0/1519856370060?e=1700697600&v=beta&t=q3RmlevnvxXrAAO8OS-7Qlbpvk-iCf5WCmyEcYuv6-k', 'url': 'https://www.linkedin.com/company/synthon/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2006}, 'end': {'month': 8, 'day': None, 'year': 2007}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 4, 'day': None, 'year': 2006}, 'end': {'month': 8, 'day': None, 'year': 2007}}, 'company': 'Synthon', 'description': 'Obtaining and improving registrations for generic medicines', 'title': 'Regulatory Affairs Officer', 'employment_type': None}]}, {'company': {'id': None, 'name': 'Department of Tumor Immunology, NCMLS, Radboud University Nijmegen Medical Centre', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 12, 'day': None, 'year': 2000}, 'end': {'month': 4, 'day': None, 'year': 2006}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 12, 'day': None, 'year': 2000}, 'end': {'month': 4, 'day': None, 'year': 2006}}, 'company': 'Department of Tumor Immunology, NCMLS, Radboud University Nijmegen Medical Centre', 'description': 'Cancer research/Immunology', 'title': 'PhD Student', 'employment_type': None}]}]",[],"['Lifesciences', 'Immunology', 'Molecular Biology', 'Oncology', 'In Vivo', 'In Vitro', 'Cell Culture', 'Biochemistry', 'Vaccines', 'Clinical Research', 'ELISA', 'Microbiology', 'Regulatory Affairs', 'Flow Cytometry', 'Life Sciences', 'Cancer', 'Animal Models', 'Inflammation', 'Innate Immunity', 'Macrophages']",,,
